A detailed history of Souders Financial Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, Souders Financial Advisors holds 39,759 shares of NVO stock, worth $4.05 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
39,759
Previous 39,696 0.16%
Holding current value
$4.05 Million
Previous $5.67 Million 16.45%
% of portfolio
0.69%
Previous 0.89%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$119.07 - $145.42 $7,501 - $9,161
63 Added 0.16%
39,759 $4.73 Million
Q2 2024

Aug 28, 2024

BUY
$122.71 - $146.91 $28,223 - $33,789
230 Added 0.58%
39,696 $5.67 Million
Q1 2024

May 08, 2024

SELL
$102.11 - $135.92 $252,518 - $336,130
-2,473 Reduced 5.9%
39,466 $5.07 Million
Q4 2023

Jan 24, 2024

SELL
$87.78 - $105.45 $51,263 - $61,582
-584 Reduced 1.37%
41,939 $4.34 Million
Q3 2023

Nov 06, 2023

BUY
$90.94 - $199.54 $1.61 Million - $3.54 Million
17,746 Added 71.62%
42,523 $3.87 Million
Q2 2023

Aug 09, 2023

SELL
$155.98 - $172.65 $356,258 - $394,332
-2,284 Reduced 8.44%
24,777 $4.01 Million
Q1 2023

May 09, 2023

SELL
$132.34 - $159.14 $22,100 - $26,576
-167 Reduced 0.61%
27,061 $4.31 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $10,665 - $14,074
104 Added 0.38%
27,228 $3.68 Million
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $507,080 - $622,301
-5,322 Reduced 16.4%
27,124 $2.7 Million
Q2 2022

Aug 05, 2022

BUY
$103.24 - $121.81 $23,332 - $27,529
226 Added 0.7%
32,446 $3.62 Million
Q1 2022

May 04, 2022

BUY
$93.1 - $112.54 $12,661 - $15,305
136 Added 0.42%
32,220 $3.58 Million
Q4 2021

Feb 04, 2022

SELL
$95.88 - $117.08 $74,211 - $90,619
-774 Reduced 2.36%
32,084 $3.59 Million
Q3 2021

Nov 03, 2021

BUY
$84.42 - $106.62 $43,054 - $54,376
510 Added 1.58%
32,858 $3.16 Million
Q2 2021

Aug 09, 2021

BUY
$67.66 - $84.76 $41,001 - $51,364
606 Added 1.91%
32,348 $2.71 Million
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $75,107 - $84,918
1,120 Added 3.66%
31,742 $2.14 Million
Q4 2020

Feb 09, 2021

BUY
$63.89 - $73.8 $38,461 - $44,427
602 Added 2.01%
30,622 $2.14 Million
Q3 2020

Nov 12, 2020

BUY
$63.69 - $70.22 $75,536 - $83,280
1,186 Added 4.11%
30,020 $2.03 Million
Q2 2020

Aug 11, 2020

BUY
$58.54 - $67.94 $813,647 - $944,298
13,899 Added 93.06%
28,834 $1.89 Million
Q1 2020

May 12, 2020

BUY
$49.46 - $64.78 $738,685 - $967,489
14,935 New
14,935 $899,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Souders Financial Advisors Portfolio

Follow Souders Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Souders Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Souders Financial Advisors with notifications on news.